BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21371189)

  • 21. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
    Petrini P
    Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric evaluation of a patient-reported symptom assessment tool for adults with haemophilia (the HAEMO-SYM).
    Rentz A; Flood E; Butler R; Christie B; Giangrande P; McCusker P; Wasserman J; Gorina E
    Haemophilia; 2009 Sep; 15(5):1039-47. PubMed ID: 19515029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose and response in haemophilia--optimization of factor replacement therapy.
    Srivastava A
    Br J Haematol; 2004 Oct; 127(1):12-25. PubMed ID: 15384973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Articular status of haemophilia patients with inhibitors.
    Morfini M
    Haemophilia; 2008 Nov; 14 Suppl 6():20-2. PubMed ID: 19134029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disability in Indian patients with haemophilia.
    Kar A; Mirkazemi R; Singh P; Potnis-Lele M; Lohade S; Lalwani A; Saha AS
    Haemophilia; 2007 Jul; 13(4):398-404. PubMed ID: 17610556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
    Fischer K; Collins P; Björkman S; Blanchette V; Oh M; Fritsch S; Schroth P; Spotts G; Ewenstein B
    Haemophilia; 2011 May; 17(3):433-8. PubMed ID: 21299740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of a disability model in haemophilia research.
    van Genderen FR; van Meeteren NL; Heijnen L; van den Berg HM; Helders PJ
    Haemophilia; 2005 Sep; 11(5):472-80. PubMed ID: 16128891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.
    den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
    Haemophilia; 2011 Jan; 17(1):41-4. PubMed ID: 20825504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impairment in daily life of obese haemophiliacs.
    Biere-Rafi S; Haak BW; Peters M; Gerdes VE; Büller HR; Kamphuisen PW
    Haemophilia; 2011 Mar; 17(2):204-8. PubMed ID: 21332881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Force fluctuations during the Maximum Isometric Voluntary Contraction of the quadriceps femoris in haemophilic patients.
    González LM; Querol F; Gallach JE; Gomis M; Aznar VA
    Haemophilia; 2007 Jan; 13(1):65-70. PubMed ID: 17212727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan.
    Liou WS; Tu TC; Cheng SN; Chou TY; Lee CF; Lin TK; Chung MI; Cham TM
    Haemophilia; 2011 Jan; 17(1):45-54. PubMed ID: 20722742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Musculoskeletal pain and functional ability in haemophilia A and B. Physiotherapy and rehabilitation in haemophilia patients.
    Santavirta N; Solovieva S; Helkama O; Lehto S; Konttinen YT; Santavirta S
    Rheumatol Int; 2001 Sep; 21(1):15-9. PubMed ID: 11678297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of depression and catastrophizing in musculoskeletal pain.
    Linton SJ; Nicholas MK; MacDonald S; Boersma K; Bergbom S; Maher C; Refshauge K
    Eur J Pain; 2011 Apr; 15(4):416-22. PubMed ID: 20884261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia.
    Rentz A; Flood E; Altisent C; Bullinger M; Klamroth R; Garrido RP; Scharrer I; Schramm W; Gorina E;
    Haemophilia; 2008 Sep; 14(5):1023-34. PubMed ID: 18665853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.